Equine Botulism Study Guide

Overview and Clinical Importance

Botulism is a rapidly progressive, often fatal neuroparalytic disease caused by neurotoxins produced by Clostridium botulinum, a gram-positive, spore-forming, obligate anaerobic bacterium. Horses are among the most susceptible domestic species to botulinum toxin, estimated to be up to 10,000 times more sensitive than mice. The disease is characterized by symmetric, flaccid paralysis resulting from blockade of acetylcholine release at the neuromuscular junction.

Botulism represents a significant topic on the NAVLE due to its rapid progression, diagnostic challenges, high mortality rate without treatment, and the importance of early recognition for successful intervention. Understanding the pathophysiology, clinical presentation, and treatment options is essential for any equine practitioner.

Etiology and Epidemiology

Causative Agent

Clostridium botulinum is a ubiquitous soil-dwelling, spore-forming, gram-positive, obligate anaerobic bacterium. The organism produces eight antigenically distinct neurotoxins designated types A through G (and recently H). In horses, types A, B, and C are clinically significant.